دورية أكاديمية
أعرض في EDS

Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic, South Korea.

التفاصيل البيبلوغرافية
العنوان: Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic, South Korea.
المؤلفون: Chang T, Cho SI, Yoo DS, Min KD
المصدر: Emerging infectious diseases [Emerg Infect Dis] 2024 Jun; Vol. 30 (6), pp. 1154-1163.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155 Publication Model: Print Cited Medium: Internet ISSN: 1080-6059 (Electronic) Linking ISSN: 10806040 NLM ISO Abbreviation: Emerg Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Atlanta, GA : National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), [1995-
مواضيع طبية MeSH: COVID-19*/epidemiology , COVID-19*/prevention & control , SARS-CoV-2*, Republic of Korea/epidemiology ; Humans ; Animals ; Incidence ; Communicable Diseases/epidemiology ; Pandemics ; Disease Notification/statistics & numerical data
مستخلص: We investigated trends in notifiable infectious diseases in both humans and animals during the COVID-19 pandemic in South Korea and compared those data against expected trends had nonpharmaceutical interventions (NPIs) not been implemented. We found that human respiratory infectious diseases other than COVID-19 decreased by an average of 54.7% after NPIs were introduced. On the basis of that trend, we estimated that annual medical expenses associated with respiratory infections other than COVID-19 also decreased by 3.8% in 2020 and 18.9% in 2021. However, human gastrointestinal infectious diseases and livestock diseases exhibited similar or even higher incidence rates after NPIs were instituted. Our investigation revealed that the preventive effect of NPIs varied among diseases and that NPIs might have had limited effectiveness in reducing the spread of certain types of infectious diseases. These findings suggest the need for future, novel public health interventions to compensate for such limitations.
References: Trop Anim Health Prod. 2022 Sep 17;54(5):309. (PMID: 36114917)
J Infect. 2021 Jan;82(1):1-35. (PMID: 33278399)
Clin Infect Dis. 2021 Feb 16;72(4):598-603. (PMID: 32594121)
Thorax. 2021 Sep;76(9):939-941. (PMID: 33782081)
Data Brief. 2020 Feb 26;29:105340. (PMID: 32181302)
J Infect Dis. 2021 Dec 1;224(11):1900-1906. (PMID: 34009376)
Pediatr Infect Dis J. 2013 Mar;32(3):217-21. (PMID: 23249909)
J Korean Med Sci. 2021 Jun 21;36(24):e180. (PMID: 34155841)
J Infect Dis. 2021 Jul 15;224(2):368-371. (PMID: 33963753)
Clin Exp Pediatr. 2022 May;65(5):250-251. (PMID: 35344981)
Emerg Infect Dis. 2021;27(6):1685-1688. (PMID: 34013875)
J Korean Med Sci. 2020 Dec 21;35(49):e433. (PMID: 33350189)
BMC Infect Dis. 2023 Oct 24;23(1):717. (PMID: 37875817)
Am J Epidemiol. 2013 Nov 1;178(9):1505-12. (PMID: 24043437)
Infect Chemother. 2015 Mar;47(1):1-11. (PMID: 25844258)
Am J Epidemiol. 2014 Nov 1;180(9):865-75. (PMID: 25294601)
Clin Infect Dis. 2021 Jul 1;73(1):e132-e140. (PMID: 32472687)
Epidemiol Health. 2022;44:e2022011. (PMID: 34990526)
PLoS Pathog. 2018 Feb 8;14(2):e1006885. (PMID: 29420641)
J Vet Sci. 2014 Dec;15(4):537-43. (PMID: 25234321)
J Prev Med Public Health. 2022 May;55(3):253-262. (PMID: 35677999)
Clin Infect Dis. 2021 Jul 30;73(Suppl 2):S120-S126. (PMID: 33009800)
Front Vet Sci. 2020 Oct 15;7:582528. (PMID: 33195601)
Nat Rev Microbiol. 2023 Mar;21(3):195-210. (PMID: 36253478)
EClinicalMedicine. 2020 Oct 24;28:100603. (PMID: 33134905)
J Med Virol. 2021 Mar;93(3):1814-1816. (PMID: 33079384)
Emerg Infect Dis. 2012 Oct;18(10):1700-2. (PMID: 23017843)
Nat Commun. 2021 May 31;12(1):3249. (PMID: 34059675)
J Educ Eval Health Prof. 2020;17:20. (PMID: 32663925)
Int J Infect Dis. 2021 Sep;110:29-35. (PMID: 34245886)
Nat Commun. 2021 Nov 26;12(1):6923. (PMID: 34836947)
Clin Infect Dis. 2022 Aug 24;75(1):e1054-e1062. (PMID: 34788811)
J Korean Med Sci. 2020 Sep 07;35(35):e321. (PMID: 32893522)
Emerg Infect Dis. 2020 Oct;26(10):2506-2508. (PMID: 32672531)
J Korean Med Sci. 2022 May 30;37(21):e172. (PMID: 35638198)
Lancet. 2022 Apr 16;399(10334):1513-1536. (PMID: 35279232)
Clin Infect Dis. 2021 Aug 2;73(3):e808-e810. (PMID: 33354719)
Clin Exp Pediatr. 2022 Apr;65(4):167-171. (PMID: 34844396)
فهرسة مساهمة: Keywords: COVID-19; Nationally notifiable; SARS-CoV-2; South Korea; coronavirus disease; infectious diseases; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine-preventable diseases; viruses; zoonoses
تواريخ الأحداث: Date Created: 20240523 Date Completed: 20240523 Latest Revision: 20240603
رمز التحديث: 20240603
مُعرف محوري في PubMed: PMC11138988
DOI: 10.3201/eid3006.231422
PMID: 38781924
قاعدة البيانات: MEDLINE
الوصف
تدمد:1080-6059
DOI:10.3201/eid3006.231422